“SOLUBLE ST2 AND CD163 AS POTENTIALBIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME” (2019) Mediterranean Journal of Hematology and Infectious Diseases, 11(1), p. e2019008. doi:10.4084/mjhid.2019.008.